Use of Long-Acting Benzodiazepines in People Aged 65 Years and Over
Identifying Attributes
Care Settings
Primary Care
Country
Organisation for Economic Co-operation and Development
Publishing Organisation
Healthcare Quality and Outcomes (HCQO) indicators; Primary Care - Prescribing Indicators
Type of Quality Indicator
Process
IOM Quality Dimension
Safety
Domain
Medications and Medication Management
Defining Attributes
Definition
Number of individuals ≥ 65 years of age on 1 January in the prescribing database using long-acting benzodiazepines (≥ 1 prescription).
Numerator
Number of individuals ≥ 65 years of age on 1 January in the prescribing database with ≥ 1 prescription long-acting benzodiazepines
Denominator
Number of individuals ≥ 65 years of age on 1 January in the prescribing database.
Exclusions
Use of Risk Adjustment
No
Risk Adjustments
Stratifications
Collection and Reporting Attributes
Type of Data Collection
Administrative data
Data Collection Methods
Reported by country to OECD
Frequency of Data Collection
Annually
Frequency of Data Collection in Days
365
Reporting Methods
Reported by country on OECD. Stat stats.oecd.org/Index.aspx?QueryId=51881
Reporting Frequency
Annually
Reporting Frequency in Days
365
Indicator Has Recommended Targets
No
Source and Reference Attributes
Evidence Source
Technical Specifications
Link to Measurement Tools
Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
Yes
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
No
Australian Consortium for Aged Care Endorsed
No
Identified by PHARMA-Care Project
No
Upload Date
04 November 2025
Contents
Actions
Date Modified 04 November 2025